Consensus DexCom, Inc. CBOE

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - CBOE 20:59:51 09/10/2026 BST			5-day change	1st Jan Change
84.08 ^USD	-0.42%		-1.53%	+26.68%

10-07	Evercore ISI Adjusts Price Target on DexCom to $110 From $90	MT
10-01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT

1ac.4o0i9Weny7SCEloJqNpHObBIToG28O3RhrsZ3nZZuHE.1r11jSrvmsXrPylu3rspFOQ-Cs75lr2J2cttpgUs4hSq4xqgDMig37FXag~58cb0a71764bc48496bf69a53847988a

Analysts' recommendations: DexCom, Inc.

10-07	Evercore ISI Adjusts Price Target on DexCom to $110 From $90	MT
10-01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
09-17	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
08-13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
08-04	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
08-03	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
08-03	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
07-31	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
07-31	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
07-31	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
07-31	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
07-31	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
07-31	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
07-31	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
07-31	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
07-31	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
07-31	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
07-31	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
07-31	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
07-31	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
07-31	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
07-31	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
07-31	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT
07-31	Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating	MT
07-31	BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+21.2%
	MEDTRONIC PLC					+18.04%
	STRYKER CORPORATION					+32.03%
	ESSILORLUXOTTICA					+53.03%
	CENCORA, INC.					+14.22%
	HOYA CORPORATION					+20.53%
	BECTON, DICKINSON AND COMPANY					+5.62%
	IDEXX LABORATORIES, INC.					+35.39%
	DEXCOM, INC.					+14.41%
	Average					+23.83%
	Weighted average by Cap.					+24.48%